Close
Close
Finance News

Arrowhead to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

4.5
4.5 from 2 votes
Tuesday, September 12, 2017

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced that the company will make presentations at the following upcoming event:

2017 Cantor Fitzgerald Global Healthcare Conference - New York, September 25-27, 2017

September 25, 9:10 a.m. EDT - Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation

A webcast of the event can be accessed on the Events and Presentations page under the Investors section of the Arrowhead website after the presentation is delivered.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/alerts.cfm.

Source: Arrowhead Pharmaceuticals
4.5
4.5 from 2 votes
Free Newsletter
Trending News